Peapod Lane Capital LLC An2 Therapeutics, Inc. Transaction History
Peapod Lane Capital LLC
- $101 Billion
- Q4 2024
A detailed history of Peapod Lane Capital LLC transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Peapod Lane Capital LLC holds 578,825 shares of ANTX stock, worth $706,166. This represents 0.79% of its overall portfolio holdings.
Number of Shares
578,825Holding current value
$706,166% of portfolio
0.79%Shares
1 transactions
Others Institutions Holding ANTX
# of Institutions
34Shares Held
14.1MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN5.75MShares$7.01 Million3.62% of portfolio
-
Ra Capital Management, L.P. Boston, MA2MShares$2.44 Million0.03% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.56MShares$1.9 Million0.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.27 Million0.0% of portfolio
-
Acuitas Investments, LLC446KShares$543,8550.23% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $23.7M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...